Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study.
Nakazawa N, Sohda M, Hosoi N, Watanabe T, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Sano A, Sakai M, Ogawa H, Shirabe K, Saeki H.
Nakazawa N, et al. Among authors: shirabe k.
Ann Surg Oncol. 2024 Dec;31(13):9023-9029. doi: 10.1245/s10434-024-16161-4. Epub 2024 Sep 3.
Ann Surg Oncol. 2024.
PMID: 39225857